Specifically, miRNA-34a suppresses expression of CD24 and Src, thereby diminishing the tumor progression-associated functions of these genes, which results in reduced expression of the oncomir miR-21, and thus relieves miR21-mediated repression of Pdcd4 and PTEN expression. The gene discussed is PDCD4; the disease is neoplasm.